Kudo‐Fujimaki, K., Hirose, T., Yoshihara, T., Sato, F., Someya, Y., Ohmura, C., . . . Watada, H. (2013). Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide. Wiley-Blackwell.

Kudo‐Fujimaki, Kyoko, Takahisa Hirose, Tomoaki Yoshihara, Fumihiko Sato, Yuki Someya, Chie Ohmura, Akio Kanazawa, Yoshio Fujitani, and Hirotaka Watada. Efficacy and Safety of Nateglinide Plus Vildagliptin Combination Therapy Compared With Switching to Vildagliptin in Type 2 Diabetes Patients Inadequately Controlled With Nateglinide. Wiley-Blackwell, 2013.

Kudo‐Fujimaki, Kyoko, et al. Efficacy and Safety of Nateglinide Plus Vildagliptin Combination Therapy Compared With Switching to Vildagliptin in Type 2 Diabetes Patients Inadequately Controlled With Nateglinide. Wiley-Blackwell, 2013.